MedPath

UNIVERSITY OF MINNESOTA

UNIVERSITY OF MINNESOTA logo
🇺🇸United States
Ownership
Private
Established
1851-01-01
Employees
10K
Market Cap
-
Website
http://www.umn.edu

Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study

Phase 2
Completed
Conditions
Chronic Insomnia
Primary Insomnia
Interventions
Behavioral: Mindfulness-Based Stress Reduction
First Posted Date
2007-08-13
Last Posted Date
2013-03-29
Lead Sponsor
University of Minnesota
Target Recruit Count
30
Registration Number
NCT00515177
Locations
🇺🇸

Minnesota Regional Sleep Disorders Center at Hennepin County Medical Center, Minneapolis, Minnesota, United States

🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

Promoting Physical Activity for Persons With Multiple Sclerosis

Not Applicable
Completed
Conditions
Multiple Sclerosis
First Posted Date
2007-08-08
Last Posted Date
2007-08-08
Lead Sponsor
University of Minnesota
Target Recruit Count
50
Registration Number
NCT00513448
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study)

Phase 3
Terminated
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
Drug: Placebo
First Posted Date
2007-06-29
Last Posted Date
2019-11-18
Lead Sponsor
University of Minnesota
Target Recruit Count
119
Registration Number
NCT00493974
Locations
🇺🇸

University of Pittsburgh Emphysema Research Center, Pittsburgh, Pennsylvania, United States

🇺🇸

HealthPartners Research Foundation, Minneapolis, Minnesota, United States

🇺🇸

University of California San Francisco-Airway Clinical Research Center, San Francisco, California, United States

and more 11 locations

Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata

Phase 2
Completed
Conditions
Alopecia Areata
Interventions
First Posted Date
2007-06-11
Last Posted Date
2018-06-29
Lead Sponsor
University of Minnesota
Target Recruit Count
18
Registration Number
NCT00484679
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

Alport Syndrome Treatments and Outcomes Registry

Recruiting
Conditions
Alport Syndrome
First Posted Date
2007-06-01
Last Posted Date
2025-03-27
Lead Sponsor
University of Minnesota
Target Recruit Count
1000
Registration Number
NCT00481130
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

Functional Neuroimaging Effects of Cognitive Remediation Training

Phase 3
Completed
Conditions
Schizophrenia
Interventions
Behavioral: Cognitive Behavioral Social Skills Training
Behavioral: Cognitive Remediation
Other: Retest in Health Controls
First Posted Date
2007-06-01
Last Posted Date
2018-05-04
Lead Sponsor
University of Minnesota
Target Recruit Count
30
Registration Number
NCT00481156
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

An Intervention to Improve End of Life Decision Making Among Homeless Persons

Not Applicable
Completed
Conditions
End of Life Decision Making
Advance Care Planning
First Posted Date
2007-05-08
Last Posted Date
2007-05-08
Lead Sponsor
University of Minnesota
Target Recruit Count
59
Registration Number
NCT00471016
Locations
🇺🇸

Listening House, St. Paul, Minnesota, United States

Health Effects of SLT, Cigarette Smoking, and New Tobacco Products

Phase 2
Completed
Conditions
Nicotine Dependence
Interventions
Other: Taboka
Other: Camel Snus
First Posted Date
2007-05-04
Last Posted Date
2019-11-01
Lead Sponsor
University of Minnesota
Target Recruit Count
130
Registration Number
NCT00469079
Locations
🇺🇸

Tobacco Use Research Center, Minneapolis, Minnesota, United States

Alfuzosin Hydrochloride to Relieve Ureteral Stent Discomfort

Phase 3
Completed
Conditions
Ureteral Stent Discomfort
First Posted Date
2007-04-30
Last Posted Date
2013-05-30
Lead Sponsor
University of Minnesota
Target Recruit Count
60
Registration Number
NCT00467467
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

Double-Blind Naltrexone in Compulsive Sexual Behavior

Phase 2
Completed
Conditions
Compulsive Sexual Behavior
Interventions
Drug: Sugar pill
First Posted Date
2007-04-30
Last Posted Date
2012-05-18
Lead Sponsor
University of Minnesota
Target Recruit Count
7
Registration Number
NCT00467558
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath